Newsramp.com Press R… · 12:25 07 May 2024
--News Direct--By James Blacker, BenzingaDespite the large numbers of people affected, cancer treatments have largely produced unsatisfactory results to curb the rise in cases. According to… Read More
Nasdaq Renb Committed Blog Posts
Monaker Group, Inc. … · 20:15 21 Nov 2023
Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy, recently announced a definitive agreement to combine with the advanced AI c… Read More
Monaker Group, Inc. … · 14:00 06 Nov 2023
Renovaro added Avram Miller, Leni Boeren, Ruud Hendriks, to the company’s board of directors
The three additions bring extensive financial backgrounds that will help as the co… Read More
Monaker Group, Inc. … · 17:18 15 Aug 2023
Renovaro BioSciences (NASDAQ: RENB), (formerly NASDAQ: ENOB), in late 2022, was awarded a U.S. patent for its proprietary cancer treatment platform that could potentially be used to induce l… Read More
Monaker Group, Inc. … · 15:03 30 Aug 2023
Renovaro BioSciences Inc. (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with shor… Read More
Monaker Group, Inc. … · 13:00 23 Aug 2023
Combination of advanced AI machine learning technology and proven immunotherapy technology seen as “future of medicine”
Demonstrated success that both companies have sho… Read More
Monaker Group, Inc. … · 15:04 16 Aug 2023
Renovaro BioSciences (NASDAQ: RENB), (formerly NASDAQ: ENOB), is focused on advancing treatments for some of the world’s deadliest diseases. In late 2022, the company announced the awa… Read More